ong-term outcomes for heart attack patients treated with a naturally-dissolving blood vessel support

Phase 4

Completed

• Conditions: Acute myocardial infarction with ST segment elevation; Circulatory System

• Registration Number: ISRCTN43696201
• Lead Sponsor: Charles University, University Research programme UNCE 02 and PROGRES Q38

Brief Summary

2016 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/27173858 interim analysis (added 05/06/2019) 2014 Other publications in https://www.ncbi.nlm.nih.gov/pubmed/24419808 pilot study (added 05/06/2019) 2020 Results article in https://www.ncbi.nlm.nih.gov/pubmed/32000796 (added 03/02/2020)

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-06-07
• Study Completion: 2020-12-15
• Last Update Posted: 1 February 2022

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 117

Inclusion Criteria

1. STEMI patients
2. Sign informed consent

Exclusion Criteria

1. Severe calcification
2. Do not meet specified vessel size
3. Length of the lesion more than 28mm
4. Indication for anticoagulation, cardiogenic shock

Study & Design

• Study Type: Observational
• Study Design: Not specified